Key points from article :
Mendaera, a Silicon Valley-based company, has raised $73 million to advance its handheld robotic system designed for medical procedures such as biopsies, organ access, and pain management. Unlike traditional surgical robots used mainly in operating rooms, Mendaera's platform combines AI, real-time imaging, and virtual connectivity to extend robotics' benefits to routine healthcare procedures. This technology aims to improve patient care, accessibility, and efficiency across healthcare systems.
Led by Threshold Ventures and supported by investors like Lux Capital and Frederic Moll, the funding will help Mendaera continue its mission to make robotics and AI more mainstream in healthcare. CEO Josh DeFonzo emphasized that robotics and AI can now bring significant benefits across the entire healthcare system, not just specialized surgeries.
Founded in 2020, Mendaera previously raised $24 million and acquired telepresence technology from Avail Medsystems. The company also partnered with Butterfly Network for point-of-care ultrasound capabilities. The surgical robotics market is growing rapidly, driven by innovations like AI, with an estimated value of $7.2 billion in 2023.
